Multimodal treatment for high-risk prostate cancer with high-dose intensity-modulated radiation therapy preceded or not by radical prostatectomy, concurrent intensified-dose docetaxel and long-term androgen deprivation therapy: results of a prospective phase II trial

BACKGROUND: The optimal management of high-risk prostate cancer remains uncertain. In this study we assessed the safety and efficacy of a novel multimodal treatment paradigm for high-risk prostate cancer. METHODS: This was a prospective phase II trial including 35 patients with newly diagnosed high-...

Descripción completa

Detalles Bibliográficos
Autores principales: Guttilla, Andrea, Bortolus, Roberto, Giannarini, Gianluca, Ghadjar, Pirus, Zattoni, Fabio, Gnech, Michele, Palumbo, Vito, Valent, Francesca, Garbeglio, Antonio, Zattoni, Filiberto
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2014
Materias:
Study Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3905924/
https://www.ncbi.nlm.nih.gov/pubmed/24423462
http://dx.doi.org/10.1186/1748-717X-9-24

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3905924/
https://www.ncbi.nlm.nih.gov/pubmed/24423462
http://dx.doi.org/10.1186/1748-717X-9-24

Ejemplares similares